Levomilnacipran Hydrochloride

Overview

Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Forest Laboratories and Pierre Fabre Group, and was approved by the Food and Drug Administration in July 2013. Levomilnacipran is the levo-enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor (SNRI).

Application

Products > Drug Discovery > Impurities > Nervous System > Milnacipran and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-263048
• CAS No.: 175131-60-9
• Molecular Formula: C15H23ClN2O
• Molecular Weight: 282.81
• Purity: 98%

Source

Original product source